Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Davis Polk Advises Mitsubishi Tanabe Pharma on Its Acquisition of NeuroDerm
Davis Polk is advising Mitsubishi Tanabe Pharma Corporation on its approximately $1.1 billion acquisition of NeuroDerm Ltd…
Akcea Therapeutics Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 17,968,750 shares of common stock of…
Dova Pharmaceuticals, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers in connection with the $86.3 million initial public offering of common…
Mersana Therapeutics, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $75…
Evolent Health, Inc. Common Stock Secondary Offering
Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000…
Royal Philips Acquires Spectranetics
Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to The Spectranetics Corporation in connection with…
Teladoc, Inc. $275 Million Convertible Senior Notes Offering
Davis Polk advised the initial purchaser in connection with a Rule 144A offering by Teladoc, Inc. of $275 million aggregate…
Bristol-Myers Squibb Company Debt Tender Offer
Davis Polk advised the dealer manager on a cash tender offer by Bristol-Myers Squibb Company for any and all of its 5.875%…
Loxo Oncology, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $260.8 million SEC-registered offering of 3,622,500…
Cardinal Health $5.2 Billion Notes Offering
Davis Polk advised the joint book-running managers in connection with the SEC-registered offering by Cardinal Health, Inc…